Saliva as a feasible alternative to blood for interrogation of somatic hematopoietic variants is a research paper published in Blood Neoplasia (2024). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Chao Family Comprehensive Cancer Center
Grant: 5P30CA062203
Chao Family Comprehensive Cancer Center
Grant: P30CA062203
National Cancer Institute
Grant: T32CA009054-43
National Center for Advancing Translational Sciences
Grant: T35DK128877-01
National Institute of General Medical Sciences
Grant: T32GM008620-23
National Institutes of Health
Grant: 5T32GM008620-23
Medical Scientist Training Program
National Institutes of Health
Grant: 3P30CA062203-27S1
Clinical Trial Advancement and Development for Sarcomas
National Institutes of Health
Grant: 2T32CA009054-16
CARCINOGENESIS
NCI NIH HHS
Grant: T32 CA009054
NIGMS NIH HHS
Grant: T32 GM008620
FWCI
0.87
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals